You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drugs Containing Excipient (Inactive Ingredient) DIMETHICONE 350


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing DIMETHICONE 350 excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Sun Pharmaceutical Industries Inc HALOG halcinonide cream 10631-094 DIMETHICONE 350
SpecGx LLC PAMELOR nortriptyline hydrochloride 0406-9910 DIMETHICONE 350
E-Z-EM Canada Inc VARIBAR NECTAR barium sulfate 32909-115 DIMETHICONE 350
E-Z-EM Canada Inc VARIBAR THIN HONEY barium sulfate 32909-121 DIMETHICONE 350
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 4 of 4 entries

Generic drugs containing DIMETHICONE 350 excipient

Dimethicone 350: Market Dynamics and Financial Trajectory

Introduction to Dimethicone 350

Dimethicone 350, also known as Dimethylpolysiloxane, is a mid-weight, non-volatile silicone widely used in the personal care and pharmaceutical industries. It is characterized by its semi-viscous clear liquid appearance, rich and smooth texture, and excellent emulsification and anti-foaming properties[2][5].

Market Applications of Dimethicone 350

Personal Care Industry

Dimethicone 350 is extensively used in the personal care sector, particularly in skin care and hair care products. It adds a silky, smooth feel to both skin and hair, making it a popular ingredient in moisturizers, cream-based cosmetics, shampoos, and conditioners. Its ability to reduce tackiness and provide a luxurious feel to products has made it a staple in the beauty industry[2][5].

Pharmaceutical Industry

In the pharmaceutical sector, dimethicone is used as an excipient in various formulations. It is utilized in antiperspirants, deodorants, and pharmaceutical products for treating gastrointestinal and dermal ailments due to its excellent moisturizing and skin-healing properties[1].

Market Trends and Drivers

Growing Demand in Personal Care

The demand for dimethicone 350 is significantly driven by the increasing use in hair care products such as shampoos and conditioners. Advances in product formulations and the rising trend of using high-quality hair care products are expected to boost the market growth[1].

Expansion in Pharmaceutical Excipients

The pharmaceutical excipients market, which includes dimethicone, is expected to grow strongly due to robust economic development in emerging markets, an upswing in the market for generic drugs, and the increasing establishment of advanced healthcare infrastructure. The market is projected to grow from $9.728 trillion in 2023 to $13.399 trillion by 2028 at a CAGR of 6.6%[3][4].

Financial Trajectory

Market Size and Growth

The dimethicone market, including dimethicone 350, is expected to experience growth despite initial setbacks due to the COVID-19 pandemic. The market slowdown caused by supply chain disruptions and reduced demand is anticipated to recover as consumption increases in various end-use applications such as moisturizers, cream-based cosmetics, shampoos, and lotions[1].

Regional Market Performance

North America and the Asia Pacific region are expected to remain key markets for pharmaceutical excipients, including dimethicone. These regions are home to major pharmaceutical and biopharmaceutical companies, which drive the demand for high-quality excipients[4].

Challenges and Restraints

Supply Chain Disruptions

The COVID-19 pandemic has caused significant supply chain disruptions, leading to a decline in dimethicone production and sales. Nationwide lockdowns and the shutdown of manufacturing units have severely impacted the market[1].

High Manufacturing Costs

High costs of manufacturing and fluctuations in raw material pricing are significant challenges for the dimethicone market. These factors can impede market growth and make it challenging for new players to enter the market[4].

Mergers and Acquisitions

The market has seen several strategic acquisitions aimed at expanding customer bases and consolidating expertise. For example, Momentive Performance Materials, Inc. acquired KCC Corporation’s silicones business in Korea and the UK, which is expected to enhance capabilities in advanced silicones[1].

Regulatory Environment

Government Initiatives

Government initiatives and regulations play a crucial role in shaping the market. For instance, the emphasis on sustainable packaging and minimizing greenhouse gas emissions is expected to influence the market dynamics in the coming years[3][4].

Competitive Landscape

Key Market Players

The dimethicone market is competitive, with key players such as TINCI, DX CHEMICAL, WYNCA, DOW CORNING, WACKER, and MOMENTIVE. These companies are involved in continuous product advancements and strategic acquisitions to maintain their market standing[1].

Future Projections

Increasing Demand for Novel Drugs

The growing demand for novel drugs and advancements in drug delivery technologies are expected to create new opportunities for dimethicone 350 in the pharmaceutical sector. The increasing sales of biologics and the development of natural and plant-based pharmaceutical excipients will also contribute to market growth[4].

Focus on Sustainability

The future market will see a focus on sustainable practices, including the use of artificial intelligence to monitor and enhance supply chain transparency, and an emphasis on reducing plastic usage in packaging[3].

Key Takeaways

  • Market Growth: Despite initial setbacks due to COVID-19, the dimethicone 350 market is expected to grow driven by increasing demand in personal care and pharmaceutical sectors.
  • Regional Performance: North America and the Asia Pacific region will remain key markets due to the presence of major pharmaceutical companies.
  • Challenges: High manufacturing costs and supply chain disruptions are significant challenges.
  • Regulatory Environment: Government initiatives on sustainability and reducing greenhouse gas emissions will influence market dynamics.
  • Competitive Landscape: Key players are engaged in product advancements and strategic acquisitions to maintain market standing.

FAQs

What is Dimethicone 350 used for?

Dimethicone 350 is used in the personal care industry for its silky, smooth texture and in the pharmaceutical industry as an excipient in various formulations.

How does the COVID-19 pandemic impact the Dimethicone 350 market?

The COVID-19 pandemic caused supply chain disruptions and reduced demand, leading to a temporary slowdown in the market. However, the market is expected to recover as consumption increases.

What are the key drivers for the Dimethicone 350 market?

Key drivers include increasing demand in hair care products, advances in pharmaceutical excipients, and robust economic development in emerging markets.

Who are the major players in the Dimethicone 350 market?

Major players include TINCI, DX CHEMICAL, WYNCA, DOW CORNING, WACKER, and MOMENTIVE.

What are the future trends expected in the Dimethicone 350 market?

Future trends include a focus on sustainability, the use of artificial intelligence in supply chains, and the development of natural and plant-based pharmaceutical excipients.

Sources

  1. Allied Market Research - Dimethicone Market Statistics, Drivers | Trends 2030
  2. Humblebee & Me - Dimethicone 350
  3. Research and Markets - Pharmaceutical Excipients Global Market Report 2024
  4. SkyQuest - Pharmaceutical Excipients Market Size and Trends| 2024-2031
  5. TKB Trading - Dimethicone 350 - DIY Beauty - Hair & Skincare

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.